Budesafe-f 400 Inhaler By Invision Medi Sciences Pvt. Ltd.

Backed by major vendors, we are established as trader, supplier and exporter of Budesafe-F 400 Inhaler in Bengaluru, Karnataka, India available with following details.

Comparison of Budesonide/Formoterol with Budesonide monotherapy

Formoterol & budesonide combination provides better clinical outcomes with longer duration of action.
Shows excellent reduction in inflammation, severe exacerbations & airway responsiveness with rapid asthma control
(Int J Clin pract 2009 oct:63(10); 1479-1488
Provides rapid onset of action within 2-3 min
Shows greater improvement in lung function & better symptomatic control compared with salmetrol.

Budesonide / Formoterol Budesonide / Monotherapy
Oneset of action More rapied and long lasting than Budesnide lesser than Budesonide/ Formoterol
Peak expiratory flow(PEF) Higher Lower than Budesonide/ Formoterol
Symptomatic relifeSuperior in lung function, asthma symptoms,
disease control & health related quality of lifeLesser symptomatic relief
than Budesonide / formoterol
Adverse effects 19% 31%
Dose Lower dose is required to achieve symptomatic relief Higher dose is required to
achive symptomatic relief

Indications:
COPD
Asthma
Bronchial asthma

Recommended Dosage:
Twice daily